All lobbying filings

INDIGO HILL STRATEGIES

Lobbying for SICK CELLS · National Sickle Cell Advocacy

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $30,000.00 income · posted Apr 16, 2026

Official filing document

Bills named in this filing 4

HR 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
S 735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
HR 5178
Sickle Cell Disease Comprehensive Care Act
S 721
Sickle Cell Disease Comprehensive Care Act

Lobbying activity 2

Budget/Appropriations

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

Health Issues

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.